Transparency Market Research published new market report "In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," market was valued at USD 46.0 billion in 2011 and is expected to reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from 2012 to 2018. Browse the full report With TOC at http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

1. REPORT DESCRIPTION
In Vitro Diagnostics Market is Expected to Reach USD 74.2 Billion Globally in 2018:
Transparency Market Research
Transparency Market Research published new market report "In Vitro Diagnostics
Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing,
Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and
Forecast, 2012 - 2018," market was valued at USD 46.0 billion in 2011 and is expected to
reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from
2012 to 2018.
In vitro diagnostics (IVDs) provide valuable information regarding the physiological and/or
pathological state of body and therefore are very essential to take well-informed medical
decisions. Rising number of patients suffering from infectious and chronic diseases such as
sexually transmitted diseases, chronic obstructive pulmonary disease, diabetes and cancer
is the most significant growth driver of this market. In addition, factors such as increasing
global healthcare expenditure and demand for rapid, minimally invasive and non-invasive
diagnostic tools & techniques are driving the market as well.
In 2011, the North America IVD market held the second largest share of the global market
at approximately 40%. The Asia-Pacific IVD market is expected to outperform all
Transparency Market Research
In Vitro Diagnostics Market
- Global Industry Analysis,
Size, Share, Growth and
Forecast, 2012 - 2018
Single User License: US $ 4595
Multi User License: US $ 7595
Corporate User License: US $ 10595
Buy Now
Request Sample
Published Date: July 2013
124 Pages Report

2. geographies in terms of growth rate during the forecast period. Presence of large patient
pool and rising healthcare expenditure in these regions are responsible for this growth.
The clinical chemistry segment of the market held the largest market share across all major
geographic regions such as the U.S., China and India in 2011. However, increase in demand
for molecular diagnostics in the IVD market is expected to cut into the market share of
clinical chemistry by 2018.
In 2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro
diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the other major
companies involved in the development, manufacturing and distribution of in vitro
diagnostics are Johnson & Johnson, Beckman Coulter Inc., Becton Dickinson and Company,
Gen-Probe Incorporated and Thermo Fisher Scientific Corporation.
The global in vitro diagnostics market is categorized into the following segments:
Market by Products
 U.S.
o Clinical Chemistry
o Immunoassay
o Diabetes Testing
o Blood Testing
o Molecular Diagnostics
o Others (Flow Cytometry, Microbiological Diagnostic Techniques)
 India
o Clinical Chemistry
o Immunoassay
o Diabetes Testing
o Blood Testing
o Molecular Diagnostics
o Others (Flow Cytometry, Microbiological Diagnostic Techniques)
 China
o Clinical Chemistry

3. o Immunoassay
o Diabetes Testing
o Blood Testing
o Molecular Diagnostics
o Others (Flow Cytometry, Microbiological Diagnostic Techniques)
Market by Geography
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)
Browse the full report at http://www.transparencymarketresearch.com/in-vitro-
diagnostic-tests.html
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Trend and Future Outlook
3.1.1 Global In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
3.2 Market Dynamics
3.2.1 Market drivers

4. 3.2.1.1 Rising Number of Patients with Infectious and Chronic Diseases
3.2.1.2 Increasing Global Healthcare Expenditure
3.2.1.3 Demand for Rapid and Minimally- or Non-Invasive Diagnostic Tools &
Techniques
3.2.1.4 Impact Analysis of the Market Drivers
3.2.2 Market Restraints
3.2.2.1 Reimbursement Challenges Retards the Growth of Market
3.2.2.2 Uncertain and Ambiguous Regulatory environment restrains In Vitro
Diagnostics market
3.2.2.3 Impact Analysis of the Market Restraints
3.2.3 Market Opportunities
3.2.3.1 Molecular Diagnostics: Key to Future
3.2.3.2 Epigenomics-Based Diagnostics expected to be an Emerging segment in
In-Vitro Diagnostic Market
3.2.4 Porter’s Five Forces Analysis for In Vitro Diagnostic Market
3.2.4.1 Bargaining Power of Suppliers
3.2.4.2 Bargaining Power of Buyers
3.2.4.3 Threat of new entrants
3.2.4.4 Threat of substitutes
3.2.5 Competitive rivalry
3.3 Market Attractiveness Analysis of the Global In-Vitro Diagnostics Market, by Geography
Chapter 4 Global In Vitro Diagnostics Market, by Products (Qualitative
information)
4.1 Overview
4.2 Clinical Chemistry
4.3 Immunoassay

5. 4.4 Diabetes Testing
4.5 Blood Testing
4.6 Molecular Diagnosis
4.7 Others
Browse the full report at http://www.transparencymarketresearch.com/in-vitro-
diagnostic-tests.html
Chapter 5 Global In Vitro Diagnostics Market, by Geography
5.1 Overview
5.2 North America
5.2.1 North America In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.3 Europe
5.3.1 Europe In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.5 Rest of the World
5.5.1 ROW In Vitro Diagnostics Market, 2010-2018 USD Million)
Chapter 6 U.S. In Vitro Diagnostics Market, by Products
6.1 Overview
6.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
6.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
6.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
6.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
6.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
6.7 Others IVD Market, 2010 – 2018 (USD Million)

6. Browse the full report at http://www.transparencymarketresearch.com/in-vitro-
diagnostic-tests.html
Chapter 7 China In Vitro Diagnostics Market, by Products
7.1 Overview
7.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
7.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
7.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
7.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
7.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
7.7 Others IVD Market, 2010 – 2018 (USD Million)
Chapter 8 India In Vitro Diagnostics Market, by Products
8.1 Overview
8.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
8.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
8.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
8.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
8.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
8.7 Others IVD Market, 2010 – 2018 (USD Million)
Chapter 9 Competitive Landscape
9.1 Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)
Chapter 10 Company Profiles
10.1 Abbott Laboratories Inc.

7. 10.1.1 Company Overview
10.1.2 Financial overview
10.1.3 Business Strategies
10.1.4 Product Portfolio
10.1.5 Recent Developments
10.2 Alere, Inc.
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Business Strategies
10.2.4 Product Portfolio
10.2.5 Recent Developments
10.3 Bayer AG
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Business Strategies
10.3.4 Product Portfolio
10.3.5 Recent Developments
10.4 Becton, Dickinson and Company
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Business Strategies
10.4.4 Product Portfolio
10.4.5 Recent Developments
10.5 Biomerieux SA
10.5.1 Company Overview

8. 10.5.2 Financial Overview
10.5.3 Business Strategies
10.5.4 Product Portfolio
10.5.5 Recent Developments
10.6 Beckman Coulter, Inc.
10.6.1 Company Overview
10.6.2 Financial overview
10.6.3 Business Strategies
10.6.4 Product portfolio
10.6.5 Recent developments
10.7 Gen-Probe Incorporated
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Business Strategies
10.7.4 Product Portfolio
10.7.5 Recent Developments
10.8 Johnson and Johnson
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Business Strategies
10.8.4 Product Portfolio
10.8.5 Recent Developments
10.9 Life Technologies Corporation
10.9.1 Company Overview
10.9.2 Financial Overview

9. 10.9.3 Business Strategies
10.9.4 Product Portfolio
10.9.5 Recent Developments
Browse the full report at http://www.transparencymarketresearch.com/in-vitro-
diagnostic-tests.html
10.10 F. Hoffmann-La Roche Ltd
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Business strategies
10.10.4 Product portfolio
10.10.5 Recent developments
10.11 Siemens Healthcare
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Business Strategies
10.11.4 Product Portfolio
10.11.5 Recent Developments
10.12 Thermo Fisher Scientific, Inc.
10.12.1 Company Overview
10.12.2 Financial overview
10.12.3 Business strategies
10.12.4 Product portfolio
10.12.5 Recent developments

10. About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/